Clinical Data for EU Reimbursement and Threshold Modeling
Sep 14, 2010
Minneapolis, USA
In this seminar we will address two key-aspects in your EU-reimbursement strategy:
- How do I develop the right clinical data for EU reimbursement
- How to evaluate if my product will be considered cost-effective
Many companies have experienced that they have done an extensive clinical trial for regulatory purposes, only to find that they have to do another trial for reimbursement. In this seminar we will outline some key-consideration that can help you align your clinical trial for EU-reimbursement.
In Europe, cost-effectiveness is an essential parameter for your reimbursement strategy. We will show an example of how it is possible to make an early evaluation if your product is likely to be considered in a European environment and the sensitivity of key-parameters in the anticipated outcomes.
Speaker:
Mattias Kyhlstedt, CEO and founder of Synergus with extensive experience in advising medical device companies about EU reimbursement and regulatory.
Agenda:
7:30 am Continental breakfast
8:00am Presentation starts
8:45am Q&A session
Time & Date:
September 14th, 2010
Breakfast is served from 7:30 am.
Location:
Doubletree Hotel Minneapolis-Park Place
1500 Park Place Blvd., Minneapolis, Minnesota, United States 55416
Continental breakfast will be provided.
Registration:
Please RSVP by September 10th by contacting Synergus at +46-8-544 767 50